- Home
- XPEV vs VKTX Comparison
XPEV vs VKTX Comparison
Compare XPEV & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEV
- VKTX
- Stock Information
- Founded
- XPEV 2015
- VKTX 2012
- Country
- XPEV China
- VKTX United States
- Employees
- XPEV N/A
- VKTX N/A
- Industry
- XPEV Auto Manufacturing
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- XPEV Consumer Discretionary
- VKTX Health Care
- Exchange
- XPEV Nasdaq
- VKTX Nasdaq
- Market Cap
- XPEV 7.6B
- VKTX 7.2B
- IPO Year
- XPEV 2020
- VKTX 2015
- Fundamental
- Price
- XPEV $12.18
- VKTX $51.15
- Analyst Decision
- XPEV Buy
- VKTX Strong Buy
- Analyst Count
- XPEV 6
- VKTX 10
- Target Price
- XPEV $12.37
- VKTX $109.80
- AVG Volume (30 Days)
- XPEV 16.1M
- VKTX 7.1M
- Earning Date
- XPEV 11-19-2024
- VKTX 10-23-2024
- Dividend Yield
- XPEV N/A
- VKTX N/A
- EPS Growth
- XPEV N/A
- VKTX N/A
- EPS
- XPEV N/A
- VKTX N/A
- Revenue
- XPEV $5,390,497,248.00
- VKTX N/A
- Revenue This Year
- XPEV $35.42
- VKTX N/A
- Revenue Next Year
- XPEV $55.58
- VKTX N/A
- P/E Ratio
- XPEV N/A
- VKTX N/A
- Revenue Growth
- XPEV 66.09
- VKTX N/A
- 52 Week Low
- XPEV $6.55
- VKTX $11.21
- 52 Week High
- XPEV $18.74
- VKTX $99.41
- Technical
- Relative Strength Index (RSI)
- XPEV 48.53
- VKTX 34.75
- Support Level
- XPEV $11.91
- VKTX $47.65
- Resistance Level
- XPEV $13.39
- VKTX $53.04
- Average True Range (ATR)
- XPEV 0.72
- VKTX 4.95
- MACD
- XPEV -0.17
- VKTX -1.69
- Stochastic Oscillator
- XPEV 11.16
- VKTX 11.13
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 141,000 EVs in 2023, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.